Want to see HK:2575 full AI Analyst Report?

Xuanzhu Biopharmaceutical Co., Ltd. Class H (2575) Income Statement

2 Followers

Xuanzhu Biopharmaceutical Co., Ltd. Class H Income Statement

Last quarter (Q2 2026), Xuanzhu Biopharmaceutical Co., Ltd. Class H's total revenue was HK$40.10M, an increase of 309.08% from the same quarter last year. In Q2, Xuanzhu Biopharmaceutical Co., Ltd. Class H's net income was HK$-43.51M. See Xuanzhu Biopharmaceutical Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Total Revenue	HK$ 56.15M	HK$ 32.63M	HK$ 32.04K	HK$ 0.00	HK$ 0.00
Gross Profit	HK$ 21.80M	HK$ -12.60M	HK$ -35.52M	HK$ -30.16M	HK$ 0.00
Operating Expenses	HK$ 274.94M	HK$ 598.67M	HK$ 339.19M	HK$ 550.08M	HK$ 565.50M
Depreciation and Amortization	HK$ 32.59M	HK$ 36.60M	HK$ 35.54M	HK$ 30.16M	HK$ 22.25M
EBITDA	HK$ -220.55M	HK$ -566.36M	HK$ -295.28M	HK$ -563.77M	HK$ -489.29M
Operating Income	HK$ -253.14M	HK$ -611.27M	HK$ -374.71M	HK$ -580.24M	HK$ -565.50M
Other Income/Expenses	HK$ -13.11M	HK$ 7.98M	HK$ 42.60M	HK$ -15.45M	HK$ -787.51K
Pretax Income	HK$ -266.25M	HK$ -603.29M	HK$ -332.11M	HK$ -595.70M	HK$ -566.28M
Net Income	HK$ -266.26M	HK$ -603.29M	HK$ -332.12M	HK$ -595.70M	HK$ -566.28M
Per Share Metrics
Basic EPS	HK$ -0.51	HK$ -1.16	HK$ -0.64	HK$ -1.15	HK$ -1.44
Diluted EPS	HK$ -0.51	HK$ -1.16	HK$ -0.64	HK$ -1.15	HK$ -1.44
Weighted Average Shares Outstanding	517.95M	517.95M	517.95M	517.95M	394.51M
Weighted Average Shares Outstanding (Diluted)	517.95M	517.95M	517.95M	517.95M	394.51M

Currency in HKD

Xuanzhu Biopharmaceutical Co., Ltd. Class H (2575) Income Statement

Xuanzhu Biopharmaceutical Co., Ltd. Class H Income Statement

Xuanzhu Biopharmaceutical Co., Ltd. Class H Earnings and Revenue History